Herpes simplex virus encephalitis is a trigger of brain autoimmunity

被引:378
作者
Armangue, Thais [1 ,2 ]
Leypoldt, Frank [1 ,3 ]
Malaga, Ignacio [4 ]
Raspall-Chaure, Miquel [2 ]
Marti, Itxaso [5 ]
Nichter, Charles [6 ]
Pugh, John [6 ]
Vicente-Rasoamalala, Monica [7 ]
Lafuente-Hidalgo, Miguel [5 ]
Macaya, Alfons [2 ]
Ke, Michael [8 ]
Titulaer, Maarten J. [9 ]
Hoeftberger, Romana [1 ,10 ]
Sheriff, Heather [11 ]
Glaser, Carol [11 ]
Dalmau, Josep [1 ,12 ,13 ]
机构
[1] Univ Barcelona, August Pi & Sunyer Biomed Res Inst IDIBAPS, Neurol Serv, Hosp Clin, E-08036 Barcelona, Spain
[2] Autonomous Univ Barcelona, Dept Pediat Neurol, Maternoinfantil Vall dHebron Hosp, Barcelona, Spain
[3] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany
[4] Asturias Cent Univ Hosp, Pediat Neurol Unit, Dept Pediat, Oviedo, Spain
[5] Donostia Univ Hosp, Pediat Neurol Sect, San Sebastian, Spain
[6] Albany Med Ctr, Pediat Neurol Serv, Albany, NY USA
[7] Autonomous Univ Barcelona, Pediat Clin Neurophysiol Serv, Maternoinfantil Vall dHebron Hosp, Barcelona, Spain
[8] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA
[9] Erasmus MC, Dept Neurol, Rotterdam, Netherlands
[10] Med Univ Vienna, Inst Neurol, Vienna, Austria
[11] Calif Dept Publ Hlth, Ctr Infect Dis, Richmond, CA USA
[12] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA
[13] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain
关键词
NMDA-RECEPTOR ENCEPHALITIS; D-ASPARTATE RECEPTOR; COMBINATION THERAPY; ANTIBODIES; RELAPSE; ACYCLOVIR;
D O I
10.1002/ana.24083
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In 5 prospectively diagnosed patients with relapsing post-herpes simplex encephalitis (HSE), N-methyl-D-aspartate receptor (NMDAR) antibodies were identified. Antibody synthesis started 1 to 4 weeks after HSE, preceding the neurological relapse. Three of 5 patients improved postimmunotherapy, 1 spontaneously, and 1 has started to improve. Two additional patients with NMDAR antibodies, 9 with unknown neuronal surface antibodies, and 1 with NMDAR and unknown antibodies, were identified during retrospective assessment of 34 HSE patients; the frequency of autoantibodies increased over time (serum, p = 0.004; cerebrospinal fluid, p = 0.04). The 3 retrospectively identified NMDAR antibody-positive patients also had evidence of relapsing post-HSE. Overall, these findings indicate that HSE triggers NMDAR antibodies and potentially other brain autoimmunity. Ann Neurol 2014;75:317-323
引用
收藏
页码:317 / 323
页数:7
相关论文
共 50 条
  • [21] Protocol for DexEnceph: a randomised controlled trial of dexamethasone therapy in adults with herpes simplex virus encephalitis
    Whitfield, Thomas
    Fernandez, Cristina
    Davies, Kelly
    Defres, Sylviane
    Griffiths, Michael
    Hooper, Cory
    Tangney, Rebecca
    Burnside, Girvan
    Rosala-Hallas, Anna
    Moore, Perry
    Das, Kumar
    Zuckerman, Mark
    Parkes, Laura
    Keller, Simon
    Roberts, Neil
    Easton, Ava
    Touati, Saber
    Kneen, Rachel
    Stahl, J. P.
    Solomon, Tom
    BMJ OPEN, 2021, 11 (07):
  • [22] Relapse in herpes simplex virus encephalitis It's not just about the virus
    Bale, James F., Jr.
    Du Pasquier, Renaud
    NEUROLOGY, 2015, 85 (20) : 1730 - 1731
  • [23] Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis
    Westman, Gabriel
    Aurelius, Elisabeth
    Ahlm, Clas
    Blennow, Kaj
    Eriksson, Kristina
    Lind, Liza
    Schliamser, Silvia
    Sund, Fredrik
    Zetterberg, Henrik
    Studahl, Marie
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (08) : 1131 - 1136
  • [24] Predictors of a Prolonged Clinical Course in Adult Patients with Herpes Simplex Virus Encephalitis
    Taira, Naoto
    Kamei, Satoshi
    Morita, Akihiko
    Ishihara, Masaki
    Miki, Kenji
    Shiota, Hiroshi
    Mizutani, Tomohiko
    INTERNAL MEDICINE, 2009, 48 (02) : 89 - 94
  • [25] Prognostic value of cerebrospinal fluid cytokine changes in herpes simplex virus encephalitis
    Kamei, Satoshi
    Taira, Naoto
    Ishihara, Masaki
    Sekizawa, Tsuyoshi
    Morita, Akihiko
    Miki, Kenji
    Shiota, Hiroshi
    Kanno, Akira
    Suzuki, Yutaka
    Mizutani, Tomohiko
    Itoyama, Yasuto
    Morishima, Tsuneo
    Hirayanagi, Kaname
    CYTOKINE, 2009, 46 (02) : 187 - 193
  • [26] Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management
    Bradshaw, Michael J.
    Venkatesan, Arun
    NEUROTHERAPEUTICS, 2016, 13 (03) : 493 - 508
  • [27] Autoimmune post-herpes simplex encephalitis of adults and teenagers
    Armangue, Thais
    Moris, German
    Cantarin-Extremera, Veronica
    Enrique Conde, Carlos
    Rostasy, Kevin
    Elena Erro, Maria
    Carlos Portilla-Cuenca, Juan
    Turon-Vinas, Eulalia
    Malaga, Ignacio
    Munoz-Cabello, Beatriz
    Torres-Torres, Carmen
    Llufriu, Sara
    Gonzalez-Gutierrez-Solana, Luis
    Gonzalez, Guillermo
    Casado-Naranjo, Ignacio
    Rosenfeld, Myrna
    Graus, Francesc
    Dalmau, Josep
    NEUROLOGY, 2015, 85 (20) : 1736 - 1743
  • [28] Valacyclovir for Herpes Simplex Encephalitis
    Pouplin, Thomas
    Pouplin, Julie Nguyen
    Pham Van Toi
    Lindegardh, Niklas
    van Doorn, H. Rogier
    Tran Tinh Hien
    Farrar, Jeremy
    Toeroek, M. Estee
    Tran Thi Hong Chau
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (07) : 3624 - 3626
  • [29] Herpes Simplex Encephalitis: an Update
    John W. Gnann
    Richard J. Whitley
    Current Infectious Disease Reports, 2017, 19
  • [30] Steroid pulse therapy in herpes simplex encephalitis
    Almalki, Dhaifallah M.
    Al-Suwaidan, Faisal B.
    NEUROSCIENCES, 2013, 18 (03) : 276 - 277